Cargando…
Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor
BACKGROUND: Breast and ovarian cancers are common malignancies among women, contributing to a significant disease burden, and are characterized by a high level of genomic instability, owing to the failure of homologous recombination repair (HRR). Pharmacological inhibition of poly(ADP-ribose) polyme...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925261/ https://www.ncbi.nlm.nih.gov/pubmed/36793373 http://dx.doi.org/10.1155/2023/1453739 |